Patients using GLP-1 drugs often experience significant reductions in body weight, improved glycemic control, and reduced cardiovascular risk factors
Hormonal Imbalance: Some clinics skip the hassle of taking new blood tests with insufficient data on clients medical reports, the treatment aggravates hormonal fluctuations
It is majorly found circulating in the blood as GLP-1(7-36) amide that is produced primarily from three tissues of the human body: enteroendocrine L cells in the distal small bowel, cells in the pancreas, and the central nervous system ( Surprisingly, it took approximately 20 years from the discovery of GLP-1 to the authorized approval of worldwide utilized GLP-1 RAs
BMI is a measure of body size based on a calculation of height and weight
The exact timeline depends on the peptide used, dosage consistency, metabolism, and your specific treatment goals